[A case of malignant nephrosclerosis without hypertension]

[Article in Turkish]

Case Reports

[Article in Turkish]

M KULEY et al. Turk Tip Cemiy Mecm. 1961 May.

. 1961 May:27:222-8.

No abstract available

Similar articles

[Production of hypertension and malignant nephrosclerosis by thyroxin in the rat].
SELYE H. SELYE H. Rev Can Biol. 1951 Jan;9(5):475-6. Rev Can Biol. 1951. PMID: 14828178 Undetermined Language. No abstract available.
Clinical pathologic conference; hypertension, malignant phase, characterized by cardiac hypertrophy, marked, predominantly left ventricle; hyperplastic arteriosclerosis and malignant nephrosclerosis.
HOPPS HC, BELLER C. HOPPS HC, et al. J Okla State Med Assoc. 1950 Aug;43(8):366-70. J Okla State Med Assoc. 1950. PMID: 14779219 No abstract available.
On the pathogenesis of red essential arterial hypertension and of malignant nephrosclerosis.
VOLHARD F. VOLHARD F. Stanford Med Bull. 1948 Feb;6(1):13-28. Stanford Med Bull. 1948. PMID: 18857649 No abstract available.
Hypertensive nephrosclerosis.
Hill GS. Hill GS. Curr Opin Nephrol Hypertens. 2008 May;17(3):266-70. doi: 10.1097/MNH.0b013e3282f88a1f. Curr Opin Nephrol Hypertens. 2008. PMID: 18408477 Review.
Continuing follow-up of malignant hypertension.
Scarpelli PT, Gallo M, De Cesaris F, Chiari G, Dedola G, Cappeli S, Becucci A, Becherelli P, Tosi B, Fanetti C, Fanelli R. Scarpelli PT, et al. J Nephrol. 2002 Jul-Aug;15(4):431-7. J Nephrol. 2002. PMID: 12243376 Review.